Animal behavior models of the mechanisms underlying antipsychotic atypicality
暂无分享,去创建一个
[1] A. Mcghie,et al. Disorders of attention and perception in early schizophrenia. , 1961, The British journal of medical psychology.
[2] M. Carlsson. The selective 5-HT2a receptor antagonist MDL 100,907 counteracts the psychomotor stimulation ensuing manipulations with monoaminergic, glutamatergic or muscarinic neurotransmission in the mouse — implications for psychosis , 2005, Journal of Neural Transmission / General Section JNT.
[3] M. Geyer,et al. Multiple serotonin receptor subtypes modulate prepulse inhibition of the startle response in rats , 1994, Neuropharmacology.
[4] M. Geyer,et al. Ontogeny of Isolation Rearing-Induced Deficits in Sensorimotor Gating in Rats , 1999, Physiology & Behavior.
[5] C. Sánchez,et al. Neurochemical and in vivo pharmacological profile of sertindole, a limbic‐selective neuroleptic compound , 1991 .
[6] R. Lubow,et al. Disruption of latent inhibition by acute administration of low doses of amphetamine , 1988, Pharmacology Biochemistry and Behavior.
[7] J. Malick,et al. Seroquel: behavioral effects in conventional and novel tests for atypical antipsychotic drug , 2005, Psychopharmacology.
[8] A. Cools,et al. Muscular rigidity and delineation of a dopamine-specific neostriatal subregion: Tonic EMG activity in rats , 1985, Brain Research.
[9] J. Rawlins,et al. Reduced latent inhibition in people with schizophrenia: an effect of psychosis or of its treatment , 1998, British Journal of Psychiatry.
[10] J. Strauss,et al. Part 1: The Concept of Premorbid Adjustment* , 1977 .
[11] M. Geyer,et al. Failure of haloperidol to block the effects of phencyclidine and dizocilpine on prepulse inhibition of startle , 1991, Biological Psychiatry.
[12] B. Ellenbroek,et al. Treatment of schizophrenia: a clinical and preclinical evaluation of neuroleptic drugs. , 1993, Pharmacology & therapeutics.
[13] J. Arnt. Differential effects of classical and newer antipsychotics on the hypermotility induced by two dose levels of D-amphetamine. , 1995, European journal of pharmacology.
[14] Dennis S. Charney,et al. Neuropsychopharmacology : The Fifth Generation of Progress , 2002 .
[15] T. Skarsfeldt. Differential effect of antipsychotics on place navigation of rats in the Morris water maze , 1996, Psychopharmacology.
[16] M. Pietraszek,et al. Chronic treatment with haloperidol diminishes the phencyclidine-induced sensorimotor gating deficit in rats , 1998, Naunyn-Schmiedeberg's Archives of Pharmacology.
[17] M. Geyer,et al. Multiple Limbic Regions Mediate the Disruption of Prepulse Inhibition Produced in Rats by the Noncompetitive NMDA Antagonist Dizocilpine , 1998, The Journal of Neuroscience.
[18] R. Padich,et al. 5-HT modulation of auditory and visual sensorimotor gating: II. Effects of the 5-HT2A antagonist MDL 100,907 on disruption of sound and light prepulse inhibition produced by 5-HT agonists in Wistar rats , 1996, Psychopharmacology.
[19] M A Geyer,et al. Disruption of prepulse inhibition and increases in locomotor activity by competitive N-methyl-D-aspartate receptor antagonists in rats. , 1999, The Journal of pharmacology and experimental therapeutics.
[20] A. Malhotra,et al. Clozapine Blunts N-Methyl-d-Aspartate Antagonist-Induced Psychosis: A Study with Ketamine , 1997, Biological Psychiatry.
[21] T. Sharma,et al. Normalization of information processing deficits in schizophrenia with clozapine. , 1999, The American journal of psychiatry.
[22] I. Weiner,et al. From an animal model of an attentional deficit towards new insights into the pathophysiology of schizophrenia. , 1992, Journal of psychiatric research.
[23] J. Slangen,et al. Animal Models in Psychopharmacology , 1991, APS: Advances in Pharmacological Sciences.
[24] G. Rose,et al. Neurophysiological studies of sensory gating in rats: Effects of amphetamine, phencyclidine, and haloperidol , 1986, Biological Psychiatry.
[25] A. Cools,et al. The olfactory tubercle as a site of action of neuroleptics with an atypical profile in the paw test: effect of risperidone, prothipendyl, ORG 5222, sertindole and olanzapine , 1995, Psychopharmacology.
[26] J. Kehne,et al. Effects of the serotonin releasers 3,4-methylenedioxymethamphetamine (MDMA), 4-chloroamphetamine (PCA) and fenfluramine on acoustic and tactile startle reflexes in rats. , 1992, The Journal of pharmacology and experimental therapeutics.
[27] Anil K Malhotra,et al. Ketamine-Induced Exacerbation of Psychotic Symptoms and Cognitive Impairment in Neuroleptic-Free Schizophrenics , 1997, Neuropsychopharmacology.
[28] G. Ma,et al. Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat. , 1989 .
[29] R Freedman,et al. Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia. , 1982, Biological psychiatry.
[30] A. Cools,et al. The paw test: a behavioural paradigm for differentiating between classical and atypical neuroleptic drugs , 2004, Psychopharmacology.
[31] M. Geyer,et al. Parametric determinants in pre-stimulus modification of acoustic startle: interaction with ketamine , 2005, Psychopharmacology.
[32] H. Struyker-Boudier,et al. (3,4‐Dihydroxyphenylimino)‐2‐imidazoline (DPI): a stimulant of α‐adrenoceptors and dopamine receptors , 1984 .
[33] D. Javitt,et al. Phencyclidine (PCP)-induced deficits of prepulse inhibition in monkeys , 2001, Neuroreport.
[34] D. Casey. Behavioral effects of sertindole, risperidone, clozapine and haloperidol inCebus monkeys , 1996, Psychopharmacology.
[35] The nucleus accumbens and forelimb muscular rigidity in rats , 2004, Experimental Brain Research.
[36] G Honigfeld,et al. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. , 1988, Archives of general psychiatry.
[37] J. Gray,et al. Latent inhibition in drug naive schizophrenics: relationship to duration of illness and dopamine D2 binding using SPET , 1995, Schizophrenia Research.
[38] N. Swerdlow,et al. Effects of LU-111995 in three models of disrupted prepulse inhibition in rats. , 1999, The Journal of pharmacology and experimental therapeutics.
[39] M. Geyer,et al. DOI disrupts prepulse inhibition of startle in rats via 5-HT2A receptors in the ventral pallidum , 1997, Brain Research.
[40] A. Cools,et al. Effects of JL13, a pyridobenzoxazepine with potential atypical antipsychotic activity, in animal models for schizophrenia. , 2001, The Journal of pharmacology and experimental therapeutics.
[41] A. Cools,et al. Animal models of schizophrenia , 2000 .
[42] A. Dickinson,et al. Amphetamine-induced disruptions of latent inhibition are reinforcer mediated: implications for animal models of schizophrenic attentional dysfunction , 1994, Psychopharmacology.
[43] N. Moore,et al. The behavioral pharmacology of olanzapine, a novel "atypical" antipsychotic agent. , 1992, The Journal of pharmacology and experimental therapeutics.
[44] Bob Oranje,et al. P50 suppression and prepulse inhibition of the startle reflex in humans: a correlational study , 1999, Biological Psychiatry.
[45] Trevor W. Robbins,et al. Isolation rearing of rats produces a deficit in prepulse inhibition of acoustic startle similar to that in schizophrenia , 1993, Biological Psychiatry.
[46] M. Geyer,et al. Psychopharmacology of prepulse inhibition in mice. , 1996, The Chinese journal of physiology.
[47] A. Cools,et al. Activity of “Seroquel” (ICI 204,636) in Animal Models for Atypical Properties of Antipsychotics: A Comparison with Clozapine , 1996, Neuropsychopharmacology.
[48] D. Javitt,et al. Reversal of phencyclidine-induced prepulse inhibition deficits by clozapine in monkeys , 2003, Psychopharmacology.
[49] David L. Braff,et al. Latent inhibition in schizophrenia , 1996, Schizophrenia Research.
[50] C. Niemegeers,et al. IS IT POSSIBLE TO PREDICT THE CLINICAL EFFECTS OF NEUROLEPTIC DRUGS (MAJOR TRANQUILLIZERS) FROM ANIMAL DATA?I. "NEUROLEPTIC ACTIVITY SPECTRA" FOR RATS. , 1965, Arzneimittel-Forschung.
[51] B. Ellenbroek. The Ethological Analysis of Monkeys in a Social Setting as an Animal Model for Schizophrenia , 1991 .
[52] D L Braff,et al. Sensorimotor gating and schizophrenia. Human and animal model studies. , 1990, Archives of general psychiatry.
[53] M. Geyer,et al. The Effects of M100907 in Pharmacological and Developmental Animal Models of Prepulse Inhibition Deficits in Schizophrenia , 1999, Neuropsychopharmacology.
[54] J. Arnt,et al. Pharmacological specificity of conditioned avoidance response inhibition in rats: inhibition by neuroleptics and correlation to dopamine receptor blockade. , 2009, Acta pharmacologica et toxicologica.
[55] M. Geyer,et al. Phencyclidine-induced deficits in prepulse inhibition of startle are blocked by prazosin, an alpha-1 noradrenergic antagonist. , 1997, The Journal of pharmacology and experimental therapeutics.
[56] A. Cools,et al. The Paw test: an animal model for neuroleptic drugs which fulfils the criteria for pharmacological isomorphism. , 1988, Life sciences.
[57] N. Swerdlow,et al. Startle response models of sensorimotor gating and habituation deficits in schizophrenia , 1990, Brain Research Bulletin.
[58] H. Shannon,et al. Behavioral pharmacology of olanzapine: a novel antipsychotic drug. , 1997, The Journal of clinical psychiatry.
[59] N. Swerdlow,et al. Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response. , 1994, The Journal of pharmacology and experimental therapeutics.
[60] M. Geyer,et al. Characterization of the Disruptions of Prepulse Inhibition and Habituation of Startle Induced by α-Ethyltryptamine , 1997, Neuropsychopharmacology.
[61] N. Swerdlow,et al. Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients. , 1994, Archives of general psychiatry.
[62] F. Bloom,et al. Psychopharmacology: The Fourth Generation of Progress , 1995 .
[63] M. Geyer,et al. Dopaminergic stimulation disrupts sensorimotor gating in the rat , 2004, Psychopharmacology.
[64] D L Braff,et al. Sensorimotor gating and thought disturbance measured in close temporal proximity in schizophrenic patients. , 1999, Archives of general psychiatry.
[65] N. Swerdlow,et al. The neural substrates for the motor-activating properties of psychostimulants: A review of recent findings , 1986, Pharmacology Biochemistry and Behavior.
[66] H. Shannon,et al. Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine and serotonin receptor subtype selective antagonists in mice , 1997, Psychopharmacology.
[67] N. Swerdlow,et al. Seroquel, clozapine and chlorpromazine restore sensorimotor gating in ketamine-treated rats , 1998, Psychopharmacology.
[68] M. Olkinuora,et al. Agranulocytosis during treatment with clozapine , 1977, European Journal of Clinical Pharmacology.
[69] D L Braff,et al. Normal P50 suppression in schizophrenia patients treated with atypical antipsychotic medications. , 2000, The American journal of psychiatry.
[70] F. Sams-Dodd. Phencyclidine‐induced stereotyped behaviour and social isolation in rats: a possible animal model of schizophrenia , 1996, Behavioural pharmacology.
[71] J. Schwartz,et al. Climbing behavior induced by apomorphine in mice: a simple test for the study of dopamine receptors in striatum , 1976, Psychopharmacology.
[72] A. Cools. Mesolimbic dopamine and its control of locomotor activity in rats: differences in pharmacology and light/dark periodicity between the olfactory tubercle and the nucleus accumbens , 2004, Psychopharmacology.
[73] M. Geyer,et al. Prepulse inhibition of the acoustic startle response is disrupted by N-ethyl-3,4-methylenedioxyamphetamine (MDEA) in the rat. , 1989, European journal of pharmacology.
[74] F. Colpaert,et al. Inhibition of methylphenidate-induced behaviors in rats: differences among neuroleptics. , 1993, The Journal of pharmacology and experimental therapeutics.
[75] A. Cools,et al. Sensory gating in rats: lack of correlation between auditory evoked potential gating and prepulse inhibition. , 1999, Schizophrenia bulletin.
[76] N. Swerdlow,et al. Central dopamine hyperactivity in rats mimics abnormal acoustic startle response in schizophrenics , 1986, Biological Psychiatry.
[77] J. Barrett,et al. Antipsychotic drug effects on the behavior of squirrel monkeys differentially controlled by noxious stimuli , 2004, Psychopharmacology.
[78] Robert Freedman,et al. Gating of auditory P50 in schizophrenics: Unique effects of clozapine , 1996, Biological Psychiatry.
[79] A. Carlsson,et al. Rodent data and general hypothesis: antipsychotic action exerted through 5-HT2A receptor antagonism is dependent on increased serotonergic tone , 1998, Journal of Neural Transmission.
[80] H. Hartman,et al. Effects of atypical antipsychotic agents on social behavior in rodents , 1993, Pharmacology Biochemistry and Behavior.
[81] J. Schwartz,et al. Unexpected potentiation by discriminant benzamide derivatives of stereotyped behaviours elicited by dopamine agonists in mice , 1985, Naunyn-Schmiedeberg's Archives of Pharmacology.
[82] J. Gray,et al. Differential Performance of Acute and Chronic Schizophrenics in a Latent Inhibition Task , 1988, The Journal of nervous and mental disease.
[83] G. Rose,et al. Dopaminergic and noradrenergic modulation of amphetamine-induced changes in auditory gating , 1991, Brain Research.
[84] K. Miczek,et al. Disruption of primate social behavior by d-amphetamine and cocaine: Differential antagonism by antipsychotics , 2004, Psychopharmacology.
[85] M. Geyer,et al. M100907, a Serotonin 5-HT2A Receptor Antagonist and Putative Antipsychotic, Blocks Dizocilpine-Induced Prepulse Inhibition Deficits in Sprague–Dawley and Wistar Rats , 1999, Neuropsychopharmacology.
[86] T. Robbins,et al. Social Isolation in the Rat Produces Developmentally Specific Deficits in Prepulse Inhibition of the Acoustic Startle Response Without Disrupting Latent Inhibition , 1994, Neuropsychopharmacology.
[87] A. Cools,et al. The role of mesolimbic and nigrostriatal dopamine in latent inhibition as measured with the conditioned taste aversion paradigm , 1997, Psychopharmacology.
[88] M. Geyer,et al. Effects of isolation rearing on startle reactivity, habituation, and prepulse inhibition in male Lewis, Sprague-Dawley, and Fischer F344 rats. , 1998, Behavioral neuroscience.
[89] D. Weinberger. Implications of normal brain development for the pathogenesis of schizophrenia. , 1987, Archives of general psychiatry.
[90] D L Braff,et al. Effects of spiperone, raclopride, SCH 23390 and clozapine on apomorphine inhibition of sensorimotor gating of the startle response in the rat. , 1991, The Journal of pharmacology and experimental therapeutics.
[91] A. Cools,et al. Simulation models for schizophrenia , 2000 .